Benign cutaneous lymphoplasia developing at the site of tattoo

Olga Yu. Olisova; N. P Teplyuk; Lusine G. Garanyan; P. M Pyatilova

doi:10.17816/dv36939

Russian Journal of Skin and Venereal Diseases ›› 2015, Vol. 18 ›› Issue (2) : 23 -26. DOI: 10.17816/dv36939

Articles

research-article

Benign cutaneous lymphoplasia developing at the site of tattoo

Author information +

History +

PDF

Abstract

Relevant published data and a clinical case with benign cutaneous lymphoid hyperplasia at the site of a multicolor tattoo are presented. The clinical picture and the diagnosis carried out by standard and noninvasive methods are described in detail. Benign cutaneous lymphoplasia was effectively treated by injections of betamethasone (diprospan) suspension into the focus.

Keywords

benign lymphoplasia / tattoo / systemic glucocorticosteroids / diprospan

Cite this article

Download citation ▾

Olga Yu. Olisova, N. P Teplyuk, Lusine G. Garanyan, P. M Pyatilova. Benign cutaneous lymphoplasia developing at the site of tattoo. Russian Journal of Skin and Venereal Diseases, 2015, 18(2): 23-26 DOI:10.17816/dv36939

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Gardair Bouchy C., Kerdraon R., Kluger N., Armingaud P., Wakosa A., Esteve E. Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo. Ann. Pathol. 2013; 33(4): 273-7. doi: 10.1016/j.annpat.2013.04.005.

[2]	Kuo W.E., Richwine E.E., Sheehan D.J. Pseudolymphomatous and lichenoid reaction to a red tattoo: a case report. Cutis. 2011; 87(2): 89-92.

[3]	Cerroni L., Borroni R.G., Massone C., Chott A., Kerl H. Cutaneous B-cell pseudolymphoma at the site of vaccination. Am. J. Dermatopathol. 2007; 29(6): 538-42.

[4]	Porto D.A., Comfere N.I., Myers L.M., Abbott J.J. Pseudolymphomatous reaction to varicella zoster virus vaccination: role of viral in situ hybridization. J. Cutan. Pathol. 2010; 37(10): 1098-102. doi: 10.1111/j.1600-0560.2009.01461.x.

[5]	Bergman R. Pseudolymphoma and cutaneous lymphoma: facts and controversies. Clin. Dermatol. 2010; 28(5): 568-74. doi:10.1016/j.clindermatol.2010.04.005.

[6]	Sangueza O.P., Yadav S., Write C.R. Jr., Braziel R.M. Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis. J. Am. Acad. Dermatol. 1992; 14(5): 408-13.

[7]	Сергеев Ю.В. Доброкачественная лимфоплазия кожи (новое в клинике, морфологии и лечении): Автореф. дис.. канд. мед. наук. М.; 1982.

[8]	Cruz F.A., Lage D., Frigerio R.M., Zaniboni M.C., Arruda L.H. Reactions to the different pigments in tattoos: a report of two cases. An Bras. Dermatol. 2010; 85(5): 708-11.

[9]	Pham-Ledard A., Vergier B., Doutre M.S., Beylot-Barry M. Disseminated cutaneous lymphoid hyperplasia of 12 years duration triggered by vaccination. Dermatology. 2010; 220(2): 176-9. doi: 10.1159/000269845.

[10]	Martin S.J., Duvic M. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab. Clin. Lymphoma Myeloma Leuk. 2011; 11(3): 286-8. doi: 10.1016/j.clml.2011.03.017.

[11]	Roo E., Villegas C., Lopez-Bran E., Jimenez E., Valle P., Sanchez-Yus E. Postzoster cutaneous pseudolymphoma. Arch. Dermatol. 1994; 130(5): 661-3.

[12]	Zinberg M., Heilman E., Glickman F. Cutaneous pseudolymphoma resulting from a tattoo. J. Dermatol. Surg. Oncol. 1982; 8(11): 955-8.

[13]	Ильин И.И., Пасечник В.А. О лечении солитарных лимфоцитом. В cборнике тезисов 5-й научно-практической конференции НИИ косметологии Минздрава РСФСР. М.; 1972.